Urinary KIM-1 in children undergoing nephrotoxic antineoplastic treatment: a prospective cohort study

Danielle Carvalho Pedrosa1, Fernanda Macedo de Oliveira Neves1, Gdayllon Cavalcante Meneses2

  • 1Medical Sciences Post-graduate Program, Department of Clinical Medicine, Universidade Federal do Ceará, Avenue Abolição, 4043, Fortaleza, Ceará, Brazil.

Abstract

Insights

Urinary kidney injury molecule-1 (KIM-1) can detect acute kidney injury (AKI) early in children receiving chemotherapy. This renal biomarker shows potential for identifying nephrotoxic treatment complications in pediatric cancer patients.

Area of Science:

  • Pediatric Nephrology
  • Oncology
  • Biomarker Research

Background:

  • Acute kidney injury (AKI) is a common and serious complication in pediatric cancer patients, often caused by nephrotoxic chemotherapy.
  • Current diagnostic methods for AKI may not be sensitive enough for early detection in this vulnerable population.
  • There is a lack of research on renal biomarkers for monitoring AKI in children undergoing chemotherapy.

Purpose of the Study:

  • To evaluate the potential of urinary kidney injury molecule-1 (KIM-1) as an early biomarker for acute kidney injury (AKI) in children receiving nephrotoxic chemotherapy.
  • To assess the ability of urinary KIM-1 to predict persistent renal impairment following chemotherapy treatment.

Main Methods:

  • A prospective study involving pediatric patients treated with methotrexate (MTX) or platinum-based chemotherapy.
  • Urinary KIM-1 levels were measured 24 hours post-chemotherapy initiation.
  • Serum creatinine (sCr) was monitored at multiple time points before and after treatment.

Main Results:

  • 21 out of 64 children (32.8%) developed AKI, predominantly stage 1.
  • Median urinary KIM-1 levels were significantly higher in children with AKI compared to those without (p < 0.01).
  • Urinary KIM-1 demonstrated good discrimination for AKI (AUC 0.82) and predicted persistent renal impairment up to three months later.

Conclusions:

  • Urinary KIM-1, measured 24 hours after chemotherapy initiation, shows promise for early AKI detection in pediatric patients.
  • This biomarker can help identify children at risk of developing acute kidney injury from MTX or platinum-class drugs.
  • Urinary KIM-1 may aid in the timely management of nephrotoxicity in pediatric cancer treatment.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
499
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
815
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
378
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
579
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
481
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.2K